Pharmacy Times

JULY 2, 2025

The FDA has approved vancomycin injection, USP (Tyzavan; Hikma Pharmaceuticals PLC), for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections in adult and pediatric patients 1 month and older for whom appropriate dosing can be achieved.

FDA

Pharmacy Times

AUGUST 5, 2025

Accessed June 10, 2025. link] Brenan M. Nurses retain top ethics rating in U.S., but below 2020 high. January 10, 2023. Accessed June 10, 2025.

Vaccines

Pharmacy Times

JULY 14, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Independent Pharmacies

Pharmacy Times

AUGUST 7, 2025

SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. Pharmacists are pivotal in educating patients, verifying prescriptions, and collaborating with prescribers to ensure safe opioid management and reduce harm.

Labelling

Pharmacy Times

JULY 22, 2025

Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. 3 More simply, the FDA is moving preclinical testing from in vivo animal models to in silico and in vitro methods.

FDA

Pharmacy Times

AUGUST 1, 2025

Here’s How. Author(s): Debra Patt, MD, PhD, MBA , Jeff Hunnicutt Key Takeaways PBMs, initially designed to reduce costs, now inflate drug prices and dominate the market, impacting patient access to affordable medications.

Specialty Pharmacies

Pharmacy Times

JULY 22, 2025

Health Aff Sch. 2024;2(4):qxae035. doi:10.1093/haschl/qxae035 Baldoni S, Amenta F, Ricci G. Telepharmacy services: present status and future perspectives: a review. Medicina (Kaunas). 2019;55(7):327.doi:10.3390/medicina55070327

Mail-Order Pharmacies

Pharmacy Times

AUGUST 8, 2025

The FDA's accelerated approval of zongertinib marks a significant advancement for patients with HER2-mutated NSCLC, offering a new treatment option.

FDA

Pharmacy Times

JUNE 27, 2025

SHOW MORE The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma. The phase 3 ECHO trial showed significant progression-free survival improvement with acalabrutinib, supporting its approval as a new standard of care for untreated MCL.

FDA

Pharmacy Times

AUGUST 8, 2025

Kanaan, PharmD, RPh Key Takeaways Metformin combined with a GLP-1 receptor agonist significantly reduces kidney impairment risk in type 2 diabetes patients with DKD compared to other combinations.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Chemotherapy

Pharmacy Times

JULY 21, 2025

link] Download Issue PDF Download RIS Articles in this issue Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. November 7, 2022.

Vaccines

Pharmacy Times

JULY 26, 2025

Although some of these medications have additional FDA-approved uses (ie, rivaroxaban to reduce the risk of thrombotic vascular events in patients with peripheral artery disease), all 4 DOACs are approved for the treatment and prevention of venous thromboembolism and stroke prevention in nonvalvular atrial fibrillation (AFib).

Compounding Pharmacies

Pharmacy Times

JULY 21, 2025

Transformative advances in continuous glucose monitoring and the impact of FDA over-thecounter approval on diabetes care. As accessible health care providers, pharmacists can educate patients on how to best use these devices, empowering them to take charge of their own health care. REFERENCES Afridi Z, Rauf SA, Ashraf SMN, Haque MA.

Compounding Pharmacies

Pharmacy Times

JUNE 4, 2025

Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies

Pharmacy Times

JUNE 12, 2025

HOPA has selected 4.0 CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. Additional information is available here.

Compounding Pharmacies

Pharmacy Times

JUNE 16, 2025

Nemolizumab targets IL-31 receptor alpha, inhibiting itch and inflammation, and is FDA-approved for use with topical therapies in patients 12 and older. The ARCADIA study showed significant improvements in eczema severity, itch reduction, and quality of life over two years.

Compounding Pharmacies

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Pharmacy Times

JUNE 20, 2025

link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. Terrie, BSPharm, RPh Key Takeaways Dysmenorrhea affects 50% to 90% of females, causing absenteeism and reduced quality of life, with primary and secondary types identified. American Pharmaceutical Association; 2025. Dysmenorrhea and endometriosis in the adolescent.

Compounding Pharmacies

Pharmacy Times

JULY 24, 2025

American Academy of Dermatology. Accessed June 5, 2025.

Compounding Pharmacies

Pharmacy Times

JUNE 18, 2025

Implementation and evaluation of social determinants of health practice models within community pharmacy. Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. J Am Pharm Assoc (2003). 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005

Immunization

Pharmacy Times

JULY 12, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Independent Pharmacies

Pharmacy Times

JULY 18, 2025

link] Download Issue PDF Download RIS Articles in this issue Blujepa From GSK Educate Patients About Safe Medication Disposal Pharmacist Spotlight: Callie Paine, PharmD Is There a Marketplace for Mail Order? Take Back Day. United States Drug Enforcement Administration. Accessed June 6, 2025. Drug disposal: drug take-back options.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 30, 2025

SHOW MORE FDA removes REMS for CAR T-cell therapies, enhancing patient access while ensuring safety in cancer treatment. 1 Image Credit: ® Clayton - stock.adobe.com “The FDA has taken the bold step to remove the Risk Evaluation and Mitigation Strategy requirement from giving CAR T therapies.

FDA

Pharmacy Times

JUNE 13, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Pharmacy Times

JUNE 23, 2025

Comprehensive pharmacist-led transitions-of-care medication management around hospital discharge adds modest cost relative to usual care: time-andmotion cost analysis. 2023;60:469580231218625.doi:10.1177/00469580231218625

Hospitals

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Immunization

Pharmacy Times

JUNE 9, 2025

SHOW MORE The FDA has approved a groundbreaking single-pill combination therapy for hypertension, enhancing cardiovascular health with triple-agent efficacy. The therapy provides a convenient single-pill regimen, potentially benefiting a broad range of patients, including those starting hypertension treatment.

FDA

Pharmacy Times

JUNE 25, 2025

link] Download Issue PDF Download RIS Articles in this issue Pharmacists Can Provide Travel Health Tips for Patients Is Fluoride Friend or Foe? Measles outbreak case definition. Texas Department of State Health Services. Updated April 10, 2025. Accessed April 28, 2025.

Vaccines

Pharmacy Times

JUNE 20, 2025

SHOW MORE The FDA approves dupilumab as the first targeted treatment for bullous pemphigoid, offering hope for patients with this debilitating skin condition. FDA officials approved dupilumab (Dupixent; Sanofi, Regeneron) for the treatment of adults with bullous pemphigoid (BP), marking the first and only targeted treatment for BP.

FDA

Pharmacy Times

JULY 25, 2025

SHOW MORE Avatrombopag gains FDA approval for pediatric ITP treatment, offering a new oral option for managing chronic thrombocytopenia in children. Common adverse reactions in pediatric patients included viral infections, nasopharyngitis, and cough, but the drug was generally well-tolerated.

Immunization

Pharmacy Times

JULY 25, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 8, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 24, 2025

Looking Ahead: Finerenone and Future Recommendations As pharmacists await FDA approval of finerenone, many are already evaluating how this new agent might influence prescribing habits. That’s the key to titrating them to the target doses, promoting long-term medication adherence, and then monitoring for [adverse] effects,” Shah said.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 8, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies

Pharmacy Times

JULY 19, 2025

A new drug application for lorundrostat is expected to be filed with the FDA in 2025. Jansen, PharmD Candidate , Mark A. Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. mmHg (p = 0.003) and 11.0

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 16, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Compounding Pharmacies